Clinical trial
Biological Effects of Maintenance Usage of Hydroxychloroquine on PAR-4 Levels in Patients With Resected Solid Tumors
NCT03015324 is registered in ClinicalTrials.gov with Peng Wang, MD PhD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biological Effects of Maintenance Usage of Hydroxychloroquine on PAR-4 Levels in Patients With Resected Solid Tumors
- Lead sponsor
- Peng Wang, MD PhD
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 8, 2017
- Completion date
- February 2, 2021
- Enrollment
- 38 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
solid tumor